Latest News about OCGN
Recent news which mentions OCGN
From InvestorPlace
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
February 21, 2022
From InvestorPlace
Ocugen Stock Is a Fairy Tale in Need of a Happy Ending
February 18, 2022
From InvestorPlace
2 Popular Robinhood Stocks to Sell Right Now
February 18, 2022
From Motley Fool
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
From InvestorPlace
Why Novavax, Dynavax, and Ocugen Are All Rising Today
February 15, 2022
From Motley Fool
Two Reasons to Skip Ocugen Stock Despite Some Good News
February 09, 2022
Tickers
OCGN
From InvestorPlace
With No Vaccine Approval, Ocugen Is the Definition of Dead Money
February 09, 2022
Tickers
OCGN
From InvestorPlace
2 Cash-Burning Growth Stocks to Stay Far Away From
February 03, 2022
From Motley Fool
3 Biotech Stocks That Could Boom or Bust in Q1
February 01, 2022
From InvestorPlace
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall Street
January 29, 2022
From Motley Fool
From Benzinga
Tickers
OCGN
From InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
Novavax Appears to be Running Out of Options
January 25, 2022
From InvestorPlace
7 Penny Stock Bubbles That Are Bound to Burst
January 21, 2022
Tags
NYSEAMERICAN:ACY,NASDAQ:BBIG,NASDAQ:GEVO,NASDAQ:ISIG,NASDAQ:MVIS,NASDAQ:OCGN,NASDAQ:PHUN
Market News
GEVO
From InvestorPlace
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
From Benzinga
Is Ocugen Stock a Buy Now?
January 20, 2022
From Motley Fool
7 Robinhood Stocks You Can Still Buy for Under $5
January 19, 2022
From InvestorPlace
Fearless retail traders could help save the stock market in 2022
January 13, 2022
From MarketWatch
Why Ocugen Stock Couldn't Outrun the Market Today
January 12, 2022
From Motley Fool
Ocugen-Bharat Biotech Partnered COVID-19 Booster Covaxin Neutralizes Omicron, Delta Variants
January 12, 2022
Tickers
OCGN
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
From Benzinga
Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals
January 11, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.